Andrea Gagnor

Major Pubblications

1. Effectiveness of the “new rope coil” composite core Suoh 0.3 guidewire in the management of coronary artery dissections. Catheter Cardiovasc Interv. 2020 Mar 18. doi: 10.1002/ccd.28851
2. Impact of Kissing Balloon in Patients Treated With Ultrathin Stents for Left Main Lesions and Bifurcations: An Analysis From the RAIN-CARDIOGROUP VII Study. Circ Cardiovasc Interv. 2020 Mar;13(3):e008325. doi: 10.1161/CIRCINTERVENTIONS.119.008325. Epub 2020 Feb 27
3. Outcomes with retrograde versus antegrade chronic total occlusion revascularization.
   Megaly M, Ali A, Saad M, Omer M, Xenogiannis I, Werner GS, Karmpaliotis D, Russo JJ, Yamane M, Garbo R, Gagnor A, Ungi I, Rinfret S, Pershad A, Wojcik J, Garcia S, Mashayekhi K, Sianos G, Galassi AR, Burke MN, Brilakis ES. Catheter Cardiovasc Interv. 2019 Nov 28
4. Safety and efficacy of polymer-free biolimus-eluting stents versus ultrathin stents in unprotected left main or coronary bifurcation: A propensity score analysis from the RAIN and CHANCE registries.
   D’Ascenzo F1, Gaido L2, Bernardi A1, Saglietto A1, Franzé A1, Ielasi A3, Trabattoni D4,5, Di Biasi M6, Infantino V7, Rognoni A8, Helft G9, Gangor A2, Latini RA10, De Luca L11, Mitomo S12, Ugo F13, Smolka G14, Huczek Z15, Cortese B16, Capodanno D17, Chieffo A18, Piazza F19, di Mario C20, Poli A21, D’Urbano M22, Romeo F23, Giammaria M2, Varbella F24,25, Sheiban I26, Escaned J27, De Ferrari GM1. Catheter Cardiovasc Interv. 2019 Aug 5. doi: 10.1002/ccd.28413
5. Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention: A Global Expert Consensus Document. Circulation. 2019 Jul 30;140(5):420-433.
6. Feasibility and safety of distal radial access for percutaneous coronary intervention using a 7 FR sheath.
   Gasparini GL, Garbo R, Gagnor A, Oreglia J, Mazzarotto P. Catheter Cardiovasc Interv. 2019 Nov 15;94(6):902
7. Infero-postero-lateral acute myocardial infarction caused by left ventricular myxoma embolism.Gaido L, Beqaraj F, Lucciola MT, Forsennati PG, Zingarelli E, Daniele L, Gagnor A, Giammaria M. G Ital Cardiol (Rome). 2019 Feb;20(2):117-119.
8. First prospective multicenter experience with left distal transradial approach for coronary chronic total occlusion interventions using a 7-french glidesheath slender. Gasparini GL, Garbo R, Gagnor A, Oreglia J, Mazzarotto P. EuroIntervention. 2018 Oct 2. pii: EIJ-D-18-00648. doi: 10.4244/EIJ-D-18-00648
9. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial. Lancet. 2018 Sep 8;392(10150):835-848. doi: 10.1016/S0140-6736(18)31714-8. Epub 2018 Aug 25
10. Retrograde approach-related epicardial collateral channel perforation successfully treated with simultaneous bilateral coils embolization: A case illustration and review. Gasparini GL, Merella P, Mazzarotto P, Gagnor A, Garbo R, Oreglia JA. Cardiovasc Revasc Med. 2018 Oct – Nov;19(7 Pt B):879-886. doi: 10.1016/j.carrev.2018.03.004. Epub 2018 Mar 8
11. Dual lumen microcatheters for complex percutaneous coronary interventions. Oreglia JA, Garbo R, Gagnor A, Gasparini GL. Cardiovasc Revasc Med. 2018 Apr;19(3 Pt A):298-305. doi: 10.1016/j.carrev.2017.09.016. Epub 2017 Oct 4
12. Galassi AR, Sumitsuji S, Boukhris M, Brilakis ES, Di Mario C, Garbo R, Spratt JC, Christiansen EH, Gagnor A, Avran A, Sianos G, Werner GS. Utility of Intravascular Ultrasound in Percutaneous Revascularization of Chronic Total Occlusions: An Overview. JACC Cardiovasc Interv. 2016 Oct 10;9(19):1979-1991
13. Cerrato E, Tomassini F, Rolfo C, Gagnor A, Varbella F. Spontaneous coronary artery dissection treated with biovascular scaffolds guided by intravascular ultrasounds imaging. Cardiovasc Interv Ther. 2016 Mar 29
14. Bivalurudin or Unfractioned Heparin in Acute Coronary Syndromes. Marco Valgimigli, M.D., Ph.D., Enrico Frigoli, M.D., Sergio Leonardi, M.D., M.H.S., Martina Rothenbühler, M.Sc., Andrea Gagnor, M.D., Paolo Calabrò, M.D., Ph.D., Stefano Garducci, M.D., Paolo Rubartelli, M.D., Carlo Briguori, M.D., Giuseppe Andò, M.D., Ph.D., Alessandra Repetto, M.D., Ugo Limbruno, M.D., Roberto Garbo, M.D., Paolo Sganzerla, M.D., Filippo Russo, M.D., Alessandro Lupi, M.D., Bernardo Cortese, M.D., Arturo Ausiello, M.D., Salvatore Ierna, M.D., Giovanni Esposito, M.D., Ph.D., Patrizia Presbitero, M.D., Andrea Santarelli, M.D., Gennaro Sardella, M.D., Ferdinando Varbella, M.D., Simone Tresoldi, M.D., Nicoletta de Cesare, M.D., Stefano Rigattieri, M.D., Ph.D., Antonio Zingarelli, M.D., Paolo Tosi, M.D., Arnoud van ’t Hof, M.D., Ph.D., Giacomo Boccuzzi, M.D., Elmir Omerovic, M.D., Ph.D., Manel Sabaté, M.D., Ph.D., Dik Heg, Ph.D., Peter Jüni, M.D., and Pascal Vranckx, M.D., Ph.D. for the MATRIX Investigators N Engl J Med 2015; 373:997-1009September 10, 2015
15. Biolimus-Eluting StenT For de-novo coRonary artery dIsease in patiENts with Diabetes mellituS: the BESTFRIENDS multicentre registry.Meliga E, Lupi A, Latib A, Gagnor A, Boccuzzi G, Alcantara M, Lombardi P, Sticchi A, Aranzulla TC, Scrocca I, Varbella F, De Benedictis M, Colombo A, Conte MR. J Cardiovasc Med (Hagerstown). 2015 Nov 21
16. Temporal changes in the current practice of primary angioplasty: a real life experience of a single high-volume center.Tomassini F, Charrier L, Varbella F, Cerrato E, Gagnor A, Rolfo C, Echavarria-Pinto M, Restrepo SP, Nevola R, Baricocchi D, Escaned J, Minniti D, Conte MR, Berchialla P, Gianino MM. Cardiovasc Revasc Med. 2015 Oct 30
17. Percutaneous treatment of chronic total occlusions: state of the art and future perspectives.Garbo R, Gagnor A, Colombo F. G Ital Cardiol (Rome). 2015 Oct;16(10):555-64
18. Feasibility of carotid artery stenting with double cerebral embolic protection in high-risk patients.Varbella F, Gagnor A, Rolfo C, Cerrato E, Bollati M, Giay Pron P, Hartwig M, Palacio Restrepo S, Reggiani M, Amarù S, Luda di Cortemiglia E, Tomassini F. Catheter Cardiovasc Interv. 2015 Sep 10. doi: 10.1002/ccd.26218.
19. Management strategies in patients affected by chronic total occlusions: results from the Italian Registry of Chronic Total Occlusions. Salvatore D. Tomasello, Marouane Boukhris, Simona Giubilato, Francesco Marza`,Roberto Garbo, Gaetano Contegiacomo , Antonio Marzocchi, Giampaolo Niccoli , Andrea Gagnor, Ferdinando Varbella, Alessandro Desideri, Paolo Rubartelli,Angelo Cioppa, Giorgio Baralis, and Alfredo R. Galassi. .European Heart Journal Advance Access
    published September 2, 2015
20. [MGuard Dacron mesh-covered stent implantation in patients with ST-elevation myocardial infarction and high thrombotic burden: in-hospital and long-term outcome in a single high-volume center].
    Cerrato E, Rolfo C, Tomassini F, Montali N, Gambino A, Infantino V, Palacio Restrepo S, Baricocchi D, Nevola R, Gagnor A, Varbella F. G Ital Cardiol (Rome). 2015 Jun;16(6):373-9. doi: 10.1714/1934.21034. Italian
21. Retrograde recanalization of chronic total occlusion in Europe: procedural,in-hospital and long term outcomes from the multicenter ERCTO Registry. A. Galassi, G. Sianos,, G Werner, J Escaned, S Tomasello, A Gagnor et al. J Am Coll Cardiol 2015; 65 (22): 2388-2400
22. Effect of Abciximab Therapy in Patients Undergoing Coronary Angioplasty for Acute ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock.
    De Felice F, Tomassini F, Fiorilli R, Gagnor A, Parma A, Cerrato E, Musto C, Nazzaro MS, Varbella F, Violini R. Circ J. 2015 Apr 24
23. Incidence, Management, and Immediate- and Long-Term Outcomes After Iatrogenic Aortic Dissection During Diagnostic or Interventional Coronary Procedures. Núñez-Gil IJ, Bautista D, Cerrato E, Salinas P, Varbella F, Omedè P, Ugo F, Ielasi A, Giammaria M, Moreno R, Pérez-Vizcayno MJ, Escaned J, De Agustin JA, Feltes G, Macaya C, Fernández-Ortiz A; Registry on Aortic Iatrogenic Dissection (RAID) Investigators.Circulation. 2015 Jun 16;131(24):2114-9 (added author in the Appendix)
24. Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by TRansradial access site and systemic implementation of angioX) sub-study.Andò G, Cortese B, Frigoli E, Gagnor A, Garducci S, Briguori C, Rubartelli P, Calabrò P, Valgimigli M;
    Catheter Cardiovasc Interv. 2015 Apr 9. doi: 10.1002/ccd.25932. [Epub ahead of print]
25. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial Dr Marco Valgimigli, Andrea Gagnor, Paolo Calabró, Enrico Frigoli, Sergio Leonardi,Tiziana Zaro, Paolo Rubartelli, Carlo Briguori, Giuseppe Andò, Alessandra Repetto, Ugo Limbruno, Bernardo Cortese, Paolo Sganzerla, Alessandro Lupi, Mario Galli, Salvatore Colangelo, Salvatore Ierna, Arturo Ausiello, Patrizia Presbitero, Gennaro Sardella, Ferdinando Varbella, Giovanni Esposito, Andrea Santarelli, Simone Tresoldi, Marco Nazzaro, Antonio Zingarelli, Nicoletta de Cesare, Stefano Rigattieri, Paolo Tosi, Cataldo Palmieri, Salvatore Brugaletta, Sunil V Rao, Dik Heg, Martina Rothenbühler, Pascal Vranckx, Prof Peter Jüni, for the MATRIX Investigators. The Lancet. In press
26. Unprotected Left-Main Coronary Angioplasty in the Elderly in a High Volume Catheterization Centre without On-Site Surgery Facilities: Immediate and Medium Term Outcome—The Old-Placet Registry, A. Gagnor, F. Tomassini, E. Cerrato, C. Rolfo, A. Gambino, S. Giolitto, E. Favro, M. Bollati, E. Tizzani, and F. Varbella
    Advances in Vascular Medicine. Volume 2015 (2015), Article ID 751293, 7 pages
27. Setting up a multidisciplinary program of carotid artery stenting in a community hospital: Initial experience of 277 patients. Varbella F, Gagnor A, Rolfo C, Cerrato E, Bollati M, Gambino A, Pron PG, Hartwig M, Reggiani M, Amarù S, di Cortemiglia EL, Tomassini F.Int J Cardiol. 2015 Jan 20;179:17-9. doi: 10.1016/j.ijcard.2014.10.070. Epub 2014 Oct 22.
28. Design and rationale for the Minimizing Adverse haemorrhagic events by TRansradial access site and systemic Implementation of angioX program.
    Valgimigli M; MATRIX investigators. Am Heart J. 2014 Dec;168(6):838-45.e6. doi: 1016/j.ahj.2014.08.013. Epub 2014 Sep 16.
29. [Clinical and economical comparison between in-house (Make) and outsourcing (Buy) management of the cardiac catheterization laboratory from two high-volume diagnostic and interventional centers: immediate and 6-month results]. Varbella F, Minniti D, Belli R, Gualano MR, Tomassini F, Gagnor A, Gambino A, Tizzani E, Montali N, Ceruti M, Gianino MM. G Ital Cardiol (Rome). 2014 Apr;15(4):233-9.
30. Randomized comparison of operator radiation exposure comparing transradial and transfemoral approach for percutaneous coronary procedures: rationale and design of the minimizing adverse haemorrhagic events by TRansradial access site and systemic implementation of angioX – RAdiation Dose study (RAD-MATRIX). Cardiovasc Revasc Med. 2014 Mar 26. pii: S1553-8389(14)00091-8. doi: 10.1016/j.carrev.2014.03.010. [Epub ahead of print]
31. Scientific foundation and possible implications for practice of the Minimizing Adverse Haemorrhagic Events by Transradial Access Site andSystemic Implementation of AngioX (MATRIX) trial. J Cardiovasc Transl Res. 2014 Feb;7(1):101-11
32. Impact of thrombus aspiration during primary percutaneous coronary intervention in cardiogenic shock complicating ST-segment elevation myocardial infarction. Cardiovasc Revasc Med. 2013 Nov-Dec;14(6):307-10
33. Clinical outcomes following percutaneous coronary intervention with drug-eluting stents versus bare metal stents in patients on chronic hemodialysis.
34. Is percutaneous coronary intervention of unprotected left main coronary artery via transradial approach feasible for skilled transfemoral operators? Initial experience in an unselected population. Cardiovasc Revasc Med. 2013 Jul-Aug;14(4):193-6
35. Primary percutaneous coronary intervention without on-site cardiac surgery backup in unselected patients with ST-segment-elevation myocardial infarction: the Rivoli ST-segment elevation myocardial infarction (RISTEMI) registry. Cardiovasc Revasc Med. 2013 Jan-Feb;14(1):9-13
36. Primary angioplasty in ST-elevation myocardial infarction due to unprotected left-main coronary disease in a high-volume catheterization center without on-site surgery facilities: immediate and medium-term outcome: the STEMI-Placet Registry. J Invasive Cardiol. 2012 Dec;24(12):645-9.
37. Chronic total occlusion treatment as a health insurance: collateral recruitability and bidirectionality. J Cardiovasc Med (Hagerstown). 2013 Dec;14(12):899-901
38. Long-term outcomes of percutaneous coronary interventions with stent implantation in patients ≤40 years old. Am J Cardiol. 2012 Jun 15;109(12):1717-21.
39. Early angio-guided complete revascularization versus culprit vessel PCI followed by ischemia-guided staged PCI in STEMI patients with multivessel disease. J Interv Cardiol. 2011 Dec;24(6):535-41.
40. Antegrade trapping balloon technique to increase support in percutaneous treatment of ‘uncrossable’ lesions: another tool for an old problem. J Cardiovasc Med (Hagerstown). 2013 Mar;14(3):247-8
41. Cardiogenic shock complicating acute myocardial infarction in the elderly: predictors of long-term survival. Catheter Cardiovasc Interv. 2011 Oct 1;78(4):505-11
42. New drug-eluting stent implantation for recalcitrant in-stent restenosis treated with drug-eluting stents. the Stent-in-Stent Cube (SIS³) registry. J Invasive Cardiol. 2011 Sep;23(9):365-8.
43. Percutaneous left main coronary disease treatment without on-site surgery back-up in patients with acute coronary syndromes: immediate and 2-year outcomes. Catheter Cardiovasc Interv. 2012 May 1;79(6):979-87
44. Perforation of the sinus of Valsalva by guiding catheter during the percutaneous coronary intervention via the right transradial approach: a very unusual complication. Catheter Cardiovasc Interv. 2011 Nov 15;78(6):888-91
45. Successful use of an extra-long hydrophilic-coated sheath in enlarged aorta to overcome extreme tortuosity of right subclavian artery via transradial approach during coronary angiography. J Invasive Cardiol. 2011 Mar;23(3):E56-7
46. Unintended stent removal during fractured-guidewire removal in emergency angioplasty. J Cardiovasc Med (Hagerstown). 2009 Nov;10(11):885-6
47. Severe multivessel coronary spasm after sirolimus-eluting stent implantation. J Cardiovasc Med (Hagerstown). 2009 Jun;10(6):485-8
48. Immediate and long-term results of treatment of complex lesions of the left anterior descending coronary artery involving a large diagonal branch with drug-eluting stents. J Cardiovasc Med (Hagerstown). 2008 Nov;9(11):1088-94
49. Recurrent restenosis after implantation of sirolimus-eluting stents in aorto-ostial lesions: successful treatment with polytetrafluoroethylene-covered stents. J Cardiovasc Med (Hagerstown). 2008 Feb;9(2):201-4
50. Primary angioplasty and routine utilization of thrombus aspiration devices: feasibility and results in a consecutive series of 486 patients. J Cardiovasc Med (Hagerstown). 2007 Apr;8(4):258-64
51. [Primary angioplasty in a patient with the May-Hegglin anomaly, a rare heredity thrombocytopenia. A case report and review of the literature]. Ital Heart J Suppl. 2005 Apr;6(4):214-7
52. [Initial experience in the management of myocardial infarction with primary angioplasty: results of the activity in two hospitals of the Turin area without on-site cardiac surgery]. Ital Heart J Suppl. 2004 Nov;5(11):847-54
53. Immediate and medium-term outcomes following the treatment of very long (> or =50 mm) chronic total coronary artery occlusions. J Invasive Cardiol. 2004 Jan;16(1):5-9.
54. Evolving standard in the treatment of coronary artery disease. Drug-eluting stents. Minerva Cardioangiol. 2003 Oct;51(5):485-92.
55. Mortality and morbidity in reoperation comparing to first intervention in coronary revascularization. J Cardiovasc Surg (Torino). 2001 Dec;42(6):713-7.
56. Myocardial infarction before the age of 40 years is associated with insulin resistance. Metabolism. 2001 Jan;50(1):30-5.
57. Acute myocardial infarction in young adults: prognostic role of angiotensin-converting enzyme, angiotensin II type I receptor, apolipoprotein E, endothelial constitutive nitric oxide synthase, and glycoprotein IIIa genetic polymorphisms at medium-term follow-up. Am Heart J. 2000 Jun;139(6):979-84.